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Roseomonas is a name coined recently by Rihs et al to 
define a group of pink-pigmented gram-negative, oxida- 
tive coccobacilli that had been previously designated as 
“pinkcoccoid” Centers for Disease Control and Preven- 
tion (CDC) groups I through IV1~2 They proposed the 
new genus, including six genomospecies, on the basis of 
biochemical reactions and DNA homology (i.e., 
Roseomonas gilardii sp nov, Roseomonas cervicalis sp 
nov, and Roseomonas fawiae sp nov, and three still 
unnamed different genomospecies 4,5, and 6). 
Although Roseomonas spp had been isolated from 
a number of clinical specimens, such as blood, catheter, 
cerebrospinal and peritoneal fluids, wounds, eye, and 
bone, the pathogenic role of this organism remains 
unclear.‘-’ This report presents a well-documented case 
of a catheter-related bacteremia attributable to R. gilardii 
in a pediatric patient. 
CASE REPORT 
A 2-year-old male with a lO-month history of acute lym- 
phoblastic leukemia was evaluated because of fever, 38°C 
after intensive chemotherapy. Physical examination 
revealed no abnormalities. The central venous catheter 
(CVC) site, which had been placed at the time of 
leukemia diagnosis, appeared normal, with no evidence 
of inflammation or any other remarkable feature. The res- 
piratory and heart rates were 20 per minute and 110 per 
minute, respectively No hepatomegaly, splenomegaly, or 
any focus suggesting infection was detected. Initial rou- 
tine laboratory tests revealed the following values: hema- 
tocrit, 30%; hemoglobin level, 10.1 mg/dL; white blood 
cell count, 2.5 103/mm3, with 42% neutrophils (absolute 
neutrophils count 11 30/mm3), 45% lymphocytes and 13% 
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monocytes; platelet count, 201,000/mm3. The erythrocyte 
sedimentation rate was 122 mm/h. 
Blood specimens were drawn from both peripheral 
venipuncture and the CVC and processed on the 
Bact/Alert (Organon Teknika Corporation, The Nether- 
lands) automated blood culture instrument. After incuba- 
tion for 24 hours, the CVC sample was flagged as positive 
for growth by the Bact/Alert system, and 24 hours later, 
the peripheral specimen also showed positive, The Gram 
stain showed short gram-negative rods. Subcultures were 
performed on tryptic soy agar supplemented with 5% 
sheep blood, MacConkey and chocolate agar media 
(Britania, Buenos Aires, Argentina). After 48 hours of incu- 
bation, colonies were observed on the blood and choco- 
late agar plates. The organism was presumptively assumed 
to belong to the genus Roseomorzus because of its growth 
characteristics (pink-pigmented colonies) and the key test 
recommended by Rihs et al (i.e., oxidase positive test and 
the lack of both acetate utilization and acid production 
from methanol).’ The organism was submitted to the 
Instituto National de Enfermedades Infecciosas and was 
finally identified as R. gilardii. Susceptibility in vitro min- 
imal inhibitory concentration (MIC) was determined by 
E-test methodology (AB Biodisk, Solna, Sweden) and the 
susceptibility patterns were as shown in Table 1. 
Empiric intravenous antibiotic therapy had been started 
with ceIta&lime (100 mg/kg/d) and amikacin (15 m-d), 
administered through a peripheral vein, and the patient was 
subsequently transferred to another medical center. 
Because he remained febrile after 48 hours of treat- 
ment, drugs were infused through the CVC. Four days 
after treatment was initiated, the patient had two febrile 
episodes, but blood cultures were negative. After 7 days, 
he was afebrile, and the echocardiogram showed mitral 
valve thickening. Two weeks later the echocardiogram 
was repeated and showed no abnormalities. The fundo- 
scopic examination was normal. Repeated blood cultures 
were negative. The catheter was removed because 
chemotherapy was finished; it was cultured, and no organ- 
isms were recovered. Antibiotic treatment was switched 
to oral ciprofloxacin. The patient improved clinically, and 
he was discharged from the hospital on the 16th day in 
good general condition. 
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Table 1. Minimum Inhibitory Concentration for 
Roseomonas gilardii Species 
Drug 
lmipenem 
Gentamicin 
Amikacin 
Ceftriaxone 
Ciprofloxacin 
Ampicillin 
Ampicillin-sulbactam 
Amoxicillin-clavulanate 
Ceftazidime 
Cefuroxime 
MIC = minimum inhibitory concentration. 
MC (kg/m L) 
0.125 
0.500 
0.250 
8.000 
1.000 
>256 
>256 
>256 
>256 
>256 
DISCUSSION 
Pink-pigmented bacteria have been increasingly isolated 
from several clinical sources over the past 3 decades. 
Gilardi and Faur studied 2 1 pink-pigmented gram-negative 
rods, reporting seven of them as an unnamed taxon, 
because they did not fit into any previously described 
species and they differed from Methylobucterium 
mesophiZicum.3 In 1989, Korvick and colleagues reported 
two cases of pink-pigmented gram-negative isolates.4 In 
the largest review of pink-pigmented bacteria, Wallace 
and co-workers studied 156 isolates received at the CDC 
since 1966 and defined four heterogeneous “pink coc- 
coid” groups (I through IV).* In fact, the proposal of a 
new bacterial genus for pink-pigmented, oxidative bac- 
teria was done by Rihs and colleagues in 1993.’ The 
genus Roseomonas differs both morphologically and bio- 
chemically from Methylobacterium, a related genus of 
another known gram-negative pink-pigmented bacillus. 
Since the genus was described, only a few well- 
documented infections associated with Roseomonas have 
been reported.6-R Indeed, Roseomonas remains as an 
unusual cause of infection, probably because of the lack 
of clear evidence of its clinical significance and because 
of microbiologic misidentification.‘,’ 
Nevertheless R. gilardii sp nov is the species most 
frequently isolated, especially from blood cultures and 
from individuals with underlying diseases, as in the case 
presented here. Results of in vitro susceptibility testing 
performed by Rihs and colleagues showed that only three 
antibiotics, imipenem, gentamicin, and amikacin, were 
active against the 42 strains tested, with most of the iso- 
lates showing resistance to broad-spectrum penicillin and 
triaxone, the strain found in the present case displayed 
a pattern similar to that recently described by Lewis and 
colleagues.” 
Clinical reports evaluating the outcome of treatment 
for infections caused by Roseomonas are limited.7~10 It is 
noteworthy that the patient reported here was success- 
fully treated with amikacin and ceftazidime in spite of in 
vitro resistance of the organism to ceftazidime. In any 
event, the contribution of antibiotic synergism or the 
catheter removal to the satisfactory outcome cannot be 
ruled out. 
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